Leukemia Research Reports Oncology

CD20 antibody–based combination therapy may reduces the adverse prognostic impact of M-protein positivity in marginal zone lymphoma

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →